Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Nonviral Transfer Technology
  • Published:

Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system

Abstract

To achieve hepatocyte-targeted in vivo gene expression, a carrier that controls both the tissue and intracellular distribution of DNA was designed and synthesized. A cationic polymer, poly(L-ornithine) (pOrn), was modified first with galactose, then with a fusigenic peptide (mHA2) to obtain Gal-pOrn-mHA2. When applied with Gal-pOrn-mHA2 to asialoglycoprotein receptor-positive cells, fluorescein-labeled DNA showed a diffuse profile, suggesting the release of DNA from endosomes and/or lysosomes by the carrier. Then the biodistribution and gene expression after intravenous injection of DNA complexes (10 μg DNA per mouse) were examined. After injection of [32P]DNA/Gal-pOrn-mHA2, about 60% of the radioactivity was recovered in the liver, mostly in parenchymal cells. A large amount (81 ng/g tissue) of transgene product (luciferase) was detected in the liver of mice injected with DNA/Gal-pOrn-mHA2, which was 280-fold greater than that obtained with DNA/DOTMA:Chol liposomes (50 μg DNA). Prior administration of galactosylated albumin reduced the gene expression to 1/100, indicating the asialoglycoprotein receptor-mediated gene transfer in liver parenchymal cells, ie hepatocytes. The luciferase activity in hepatocytes contributed more than 95% of the total activity in all the tissues examined. Thus, hepatocyte-targeted in vivo gene expression was achieved by the intravenous injection of DNA complex with the multifunctional gene carrier.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Anderson WF . Human gene therapy Nature 1998 392: (Suppl.) 25–30

    Article  CAS  PubMed  Google Scholar 

  2. Mahato RI, Takakura Y, Hashida M . Nonviral vectors for in vivo gene delivery: physicochemical and pharmacokinetic considerations Crit Rev Ther Drug Carrier Syst 1997 14: 133–172

    Article  CAS  PubMed  Google Scholar 

  3. Lee RJ, Huang L . Lipidic vector systems for gene transfer Crit Rev Ther Drug Carrier Syst 1997 14: 173–206

    Article  CAS  PubMed  Google Scholar 

  4. Ledley FD . Nonviral gene therapy: the promise of genes as pharmaceutical products Hum Gene Ther 1995 6: 1129–1144

    Article  CAS  PubMed  Google Scholar 

  5. Curiel DT et al. Adenovirus enhancement of transferrin-polylysine-mediated gene delivery Proc Natl Acad Sci USA 1991 88: 8850–8854

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Cristiano RJ, Smith LC, Woo SLC . Hepatic gene therapy: adenovirus enhancement of receptor-mediated gene delivery and expression in primary hepatocytes Proc Natl Acad Sci USA 1993 90: 2122–2126

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Wu GY et al. Incorporation of adenovirus into a ligand-based DNA carrier system results in retention of the original receptor specificity and enhances targeted gene expression J Biol Chem 1994 269: 11542–11546

    CAS  PubMed  Google Scholar 

  8. Kaneda Y, Iwai K, Uchida T . Increased expression of DNA cointroduced with nuclear protein in adult rat liver Science 1989 243: 375–378

    Article  CAS  PubMed  Google Scholar 

  9. Kato K et al. Expression of hepatitis B virus surface antigen in adult rat liver. Co-introduction of DNA and nuclear protein by a simplified liposome method J Biol Chem 1991 266: 3361–3364

    CAS  PubMed  Google Scholar 

  10. Pinnaduwage P, Schmitt L, Huang L . Use of a quaternary ammonium detergent in liposome mediated DNA transfection of mouse L-cells Biochim Biophys Acta 1989 985: 33–37

    Article  CAS  PubMed  Google Scholar 

  11. Wagner E et al. Influenza virus hemagglutinin HA-2 N-terminal fusigenic peptides augment gene transfer by transferrin-polylysine/DNA complexes: towards a synthetic virus-like gene transfer vehicle Proc Natl Acad Sci USA 1992 89: 7934–7938

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Gottschalk S et al. A novel DNA–peptide complex for efficient gene transfer and expression in mammalian cells Gene Therapy 1996 3: 448–457

    CAS  PubMed  Google Scholar 

  13. Plank C et al. The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems J Biol Chem 1994 269: 12918–12924

    CAS  PubMed  Google Scholar 

  14. Wu GY, Wu CH . Gene therapy by targeting nucleic acids to hepatocytes. In: Arias IM et al (eds). The Liver: Biology and Pathobiology, third edition Raven Press: New York 1994 pp 1537–1556

  15. Wilson JM . Round two for liver gene therapy Nat Genet 1996 12: 232–233

    Article  CAS  PubMed  Google Scholar 

  16. Zhu N et al. Systemic gene expression after intravenous DNA delivery into adult mice Science 1993 261: 209–211

    Article  CAS  PubMed  Google Scholar 

  17. Song YK et al. Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration Hum Gene Ther 1997 8: 1585–1594

    Article  CAS  PubMed  Google Scholar 

  18. Li S, Huang L . In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes Gene Therapy 1997 4: 891–900

    Article  CAS  PubMed  Google Scholar 

  19. Mahato RI et al. In vivo disposition characteristics of plasmid DNA complexed with cationic liposomes J Drug Targeting 1995 3: 149–157

    Article  CAS  Google Scholar 

  20. Osaka G et al. Pharmacokinetics, tissue distribution, and expression efficiency of plasmid 32P-DNA following intravenous administration of DNA/cationic lipid complexes in mice: use of a novel radionuclide approach J Pharm Sci 1996 85: 612–618

    Article  CAS  PubMed  Google Scholar 

  21. Hara T, Tan Y, Huang L . In vivo gene delivery to the liver using reconstituted chylomicron remnants as a novel nonviral vector Proc Natl Acad Sci USA 1997 94: 14547–14552

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Budker V et al. Naked DNA delivered intraportally expresses efficiently in hepatocytes Gene Therapy 1996 3: 593–598

    CAS  PubMed  Google Scholar 

  23. Ledley FD et al. Retroviral gene transfer into primary hepatocytes: implications for genetic therapy of liver-specific functions Proc Natl Acad Sci USA 1987 84: 5335–5339

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Ferry N et al. Retrovirus-mediated gene transfer into hepatocytes in vivo Proc Natl Acad Sci USA 1991 88: 8377–8381

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Grossman M et al. Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia Nat Genet 1994 6: 335–341

    Article  CAS  PubMed  Google Scholar 

  26. Wu GY, Wu CH . Receptor-mediated in vitro gene transfections by a soluble DNA carrier complexes J Biol Chem 1986 262: 4429–4432

    Google Scholar 

  27. Wu GY, Wu CH . Receptor-mediated gene delivery and expression in vivo J Biol Chem 1991 263: 14621–14624

    Google Scholar 

  28. Perales JC et al. Biochemical and functional characterization of DNA complexes capable of targeting genes to hepatocytes via the asialoglycoprotein receptor J Biol Chem 1997 272: 7398–7407

    Article  CAS  PubMed  Google Scholar 

  29. Perales JC et al. Gene transfer in vivo: sustained expression and regulation of genes introduced into the liver by receptor-mediated uptake Proc Natl Acad Sci USA 1994 91: 4086–4090

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Nishikawa M et al. Targeted delivery of plasmid DNA to hepatocytes in vivo: optimization of the pharmacokinetics of plasmid DNA/galactosylated poly(L-lysine) complexes by controlling their physicochemical properties J Pharmacol Exp Ther 1998 287: 408–415

    CAS  PubMed  Google Scholar 

  31. Hashida M et al. Targeted delivery of plasmid DNA complexed with galactosylated poly(L-lysine) J Control Rel 1998 53: 301–310

    Article  CAS  Google Scholar 

  32. Kawabata K, Takakura Y, Hashida M . The fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptake Pharm Res 1995 12: 825–830

    Article  CAS  PubMed  Google Scholar 

  33. Nishikawa M et al. Galactosylated proteins are recognized by the liver according to the surface density of galactose moieties Am J Physiol 1995 268: G849–G856

    CAS  PubMed  Google Scholar 

  34. Nishikawa M et al. Pharmacokinetics of receptor-mediated hepatic uptake of glycosylated albumin in mice Int J Pharm 1992 85: 75–85

    Article  CAS  Google Scholar 

  35. Bennett HS, Luft JH, Hampton JC . Morphological classification of vertebrate blood capillaries Am J Physiol 1959 196: 381–390

    Article  CAS  PubMed  Google Scholar 

  36. Takakura Y et al. Characterization of plasmid DNA binding and uptake by peritoneal macrophages from class A scavenger receptor knockout mice Pharm Res 1999 16: 503–508

    Article  CAS  PubMed  Google Scholar 

  37. Perales JC et al. An evaluation of receptor-mediated gene transfer using synthetic DNA–ligand complexes Eur J Biochem 1994 226: 225–266

    Article  Google Scholar 

  38. Plank C, Zauner W, Wagner E . Application of membrane-active peptides for drug and gene delivery across cellular membranes Adv Drug Delivery Rev 1998 34: 21–35

    Article  CAS  Google Scholar 

  39. Liu Y et al. Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery Nat Biotechnol 1997 15: 167–173

    Article  CAS  PubMed  Google Scholar 

  40. Song YK, Liu F, Liu D . Enhanced gene expression in mouse lung by prolonging the retention time of intravenously injected plasmid DNA Gene Therapy 1998 5: 1531–1537

    Article  CAS  PubMed  Google Scholar 

  41. Löser P et al. Reactivation of the previously silenced cytomegalovirus major immediate–early promoter in the mouse liver: involvement of NFκB J Virol 1998 72: 180–190

    PubMed  PubMed Central  Google Scholar 

  42. Sambrook K, Fritsch EF, Maniatis T . Molecular Cloning: A Laboratory Manual, 2nd edn Cold Spring Harbor Laboratory Press: Plainview: New York 1989

    Google Scholar 

  43. Atherton E et al. The polyamide method of solid phase peptide and oligonucleotide synthesis Bioorg Chem 1979 8: 351–370

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nishikawa, M., Yamauchi, M., Morimoto, K. et al. Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system. Gene Ther 7, 548–555 (2000). https://doi.org/10.1038/sj.gt.3301140

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301140

Keywords

This article is cited by

Search

Quick links